British pharmaceutical giant AstraZeneca said Monday an interim analysis of clinical trials showed its coronavirus vaccine has an average efficacy of 70% in protecting against the virus.
It comes after a string of encouraging vaccine results in recent weeks, following late-stage trial readouts from Pfizer–BioNTech and Moderna.
Pfizer and Moderna reported preliminary results showing that their respective Covid vaccines were around 95% effective.